Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000669199 | SCV000793928 | likely pathogenic | Ellis-van Creveld syndrome | 2017-09-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001216770 | SCV001388582 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2023-11-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg1200*) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of EVC2-related conditions (Invitae). ClinVar contains an entry for this variant (Variation ID: 553692). For these reasons, this variant has been classified as Pathogenic. |